The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Efficacy and safety of antidepressants for the treatment of back pain and osteoarthritis: systematic review and meta-analysis
Open accessPublished version of a preprint
Abstract
Objective: To investigate the efficacy and safety of antidepressants for back and osteoarthritis pain compared with placebo. Design: Systematic review and meta-analysis. Data sources: Medline, Embase, Cochrane Central Register of Controlled Trials, CINAHL, International Pharmaceutical Abstracts, ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform from inception to 15 November and updated on 12 May 2020. Eligibility criteria for study selection: Randomised controlled trials comparing the efficacy or safety, or both of any antidepressant drug with placebo (active or inert) in participants with low back or neck pain, sciatica, or hip or knee osteoarthritis. Data extraction and synthesis: Two independent reviewers extracted data. Pain and disability were primary outcomes. Pain and disability scores were converted to a scale of 0 (no pain or disability) to 100 (worst pain or disability). A random effects model was used to calculate weighted mean differences and 95% confidence intervals. Safety (any adverse event, serious adverse events, and proportion of participants who withdrew from trials owing to adverse events) was a secondary outcome. Risk of bias was assessed with the Cochrane Collaboration’s tool and certainty of evidence with the grading of recommendations assessment, development and evaluation (GRADE) framework. Results: 33 trials (5318 participants) were included. Moderate certainty evidence showed that serotonin-noradrenaline reuptake inhibitors (SNRIs) reduced back pain (mean difference −5.30, 95% confidence interval −7.31 to −3.30) at 3-13 weeks and low certainty evidence that SNRIs reduced osteoarthritis pain (−9.72, −12.75 to −6.69) at 3-13 weeks. Very low certainty evidence showed that SNRIs reduced sciatica at two weeks or less (−18.60, −31.87 to −5.33) but not at 3-13 weeks (−17.50, −42.90 to 7.89). Low to very low certainty evidence showed that tricyclic antidepressants (TCAs) did not reduce sciatica at two weeks or less (−7.55, −18.25 to 3.15) but did at 3-13 weeks (−15.95, −31.52 to −0.39) and 3-12 months (−27.0, −36.11 to −17.89). Moderate certainty evidence showed that SNRIs reduced disability from back pain at 3-13 weeks (−3.55, −5.22 to −1.88) and disability due to osteoarthritis at two weeks or less (−5.10, −7.31 to −2.89), with low certainty evidence at 3-13 weeks (−6.07, −8.13 to −4.02). TCAs and other antidepressants did not reduce pain or disability from back pain. Conclusion: Moderate certainty evidence shows that the effect of SNRIs on pain and disability scores is small and not clinically important for back pain, but a clinically important effect cannot be excluded for osteoarthritis. TCAs and SNRIs might be effective for sciatica, but the certainty of evidence ranged from low to very low. Systematic review registration: PROSPERO CRD42020158521.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Cumpston, M., Li, T., Page, M. J., Chandler, J., Welch, V. A., Higgins, J. P., & Thomas, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.ed000142 · Cited by 7,218
What low back pain is and why we need to pay attention
Hartvigsen, J., Hancock, M. J., Kongsted, A., Louw, Q., Ferreira, M. L., Genevay, S., Hoy, D., Karppinen, J., Pransky, G., Sieper, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30480-x · Cited by 4,652
Self-citationPharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471
Qaseem, A., Wilt, T. J., McLean, R. M., Forciea, M. A., & for the Clinical Guidelines Committee of the American College of Physicians* (2017) · Annals of Internal Medicine · doi:10.7326/m16-2367 · Cited by 3,234
GRADE guidelines 6. Rating the quality of evidence—imprecision
Guyatt, G. H., Oxman, A. D., Kunz, R., Brozek, J., Alonso-Coello, P., Rind, D., Devereaux, P. J., Montori, V. M., Freyschuss, B., Vist, G., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.01.012 · Cited by 2,693
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24131 · Cited by 2,516
Research works printed but not linked: 50
- 10.1016/S0140-6736(18)32279-7 · DOI · Paper page
- 10.1136/annrheumdis-2013-204763 · DOI · Paper page
- 10.1016/j.spinee.2011.03.017 · DOI · Paper page
- 10.1017/S0033291716002099 · DOI
- 10.1371/journal.pone.0231675 · doi:10.1371/journal.pone.0231675
- 10.1016/j.joca.2019.06.011 · DOI · Paper page
- 10.1002/art.41142 · DOI · Paper page
- 10.1136/bmj.e497 · DOI · Paper page
- 10.7326/M16-2458 · DOI · Paper page
- 10.3904/kjim.2018.460 · DOI
- 10.1016/j.jclinepi.2019.12.006 · DOI
- 10.1136/bmj.b2535 · DOI · Paper page
- 10.1136/bmj.d5928 · DOI · Paper page
- 10.1002/ejp.1505 · DOI
- 10.1016/j.jclinepi.2013.02.018 · DOI
- 10.1001/jamainternmed.2016.1251 · DOI · Paper page
- 10.1016/j.joca.2015.07.001 · DOI
- Bellamy, 1988, Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee, J Rheumatol, 15, 1833
- 10.1097/ALN.0000000000000902 · DOI
- 10.1371/journal.pone.0195776 · DOI
- 10.1016/j.pain.2006.10.029 · DOI · Paper page
- 10.1016/j.jpain.2005.05.002 · DOI
- 10.1097/00007632-198307000-00012 · doi:10.1097/00007632-198307000-00012
- 10.1097/BRS.0000000000001707 · DOI
- 10.4088/PCC.14m01658 · DOI
- 10.1016/j.jpain.2010.03.002 · DOI · Paper page
- 10.1111/j.1468-1331.2009.02648.x · DOI · Paper page
- 10.1097/BRS.0b013e3181d3cef6 · DOI · Paper page
- 10.1176/appi.psy.41.6.490 · DOI
- 10.1097/00004714-199008000-00006 · doi:10.1097/00004714-199008000-00006
- Jenkins, 1976, Tofranil in the treatment of low back pain, J Int Med Res, 4, 28
- 10.2147/JPR.S164128 · DOI
- 10.1016/j.joca.2016.12.025 · DOI
- 10.1016/j.pain.2009.06.024 · DOI · Paper page
- 10.1111/j.1533-2500.2010.00401.x · DOI · Paper page
- 10.1185/03007995.2011.633502 · DOI
- Alcoff, 1982, Controlled trial of imipramine for chronic low back pain, J Fam Pract, 14, 841
- Hameroff, 1982, Doxepin effects on chronic pain, depression and plasma opioids, J Clin Psychiatry, 43, 22
- Pirbudak, 2003, Epidural steroid injection and amitriptyline in the management of acute low back pain originating from lumbar disc herniation, Joint Dis Rel Surg., 14, 89
- 10.1093/ageing/afs072 · DOI
- 10.1002/ejp.1206 · DOI
- 10.1097/ALN.0000000000000508 · DOI
- 10.3389/fneur.2017.00307 · DOI
- 10.1080/00031305.2018.1537889 · DOI
- 10.1097/j.pain.0000000000001834 · DOI
- 10.1001/jamainternmed.2018.4222 · DOI
- 10.1097/jcp.0b013e3180333ed5 · DOI
- 10.1016/S0304-3959(99)00082-2 · DOI · Paper page
- 10.1016/S0304-3959(98)00064-5 · DOI · Paper page
- 10.1371/journal.pbio.1002570 · DOI · Paper page
Cited by
Chiarotto, A., & Koes, B. W. (2022) · New England Journal of Medicine · doi:10.1056/nejmcp2032396 · Cited by 264
Associations between chronic pain, anxiety, and depression among adults in the United States
Mullins, P. M., Yong, R. J., & Bhattacharyya, N. (2023) · Pain Practice · doi:10.1111/papr.13220 · Cited by 98
“Notably, a variety of medication classes have been shown some efficacy in the treatment of both depression and chronic pain, including tricyclic antidepressants, serotoninnorepinephrine reuptake inhibitors (SNRIs), selective serotonin reuptake inhibitors (SSRIs), gabapentinoids, and antiepileptic drugs.(30) Many of th…”
BackgroundDove, L., Jones, G., Kelsey, L. A., Cairns, M. C., & Schmid, A. B. (2023) · European Spine Journal · doi:10.1007/s00586-022-07356-y · Cited by 31
“Pharmacological options fail to demonstrate effects beyond placebo [37], including non-steroidal anti-inflammatories [38], anti-convulsants [39], anti-depressants [40] or opioids [4, 41].”
Transcriptional and cellular signatures of cortical morphometric remodelling in chronic pain
Martins, D., Dipasquale, O., Veronese, M., Turkheimer, F., Loggia, M. L., McMahon, S., Howard, M. A., & Williams, S. C. R. (2022) · Pain · doi:10.1097/j.pain.0000000000002480 · Cited by 27
Analgesia for non-specific low back pain
Jones, C. M. P., Underwood, M., Chou, R., Schoene, M., Sabzwari, S., Cavanagh, J., & Lin, C.-W. C. (2024) · BMJ · doi:10.1136/bmj-2024-080064 · Cited by 21
Self-citationCojocaru, C.-M., Popa, C. O., Schenk, A., Jakab, Z., Suciu, B. A., Olah, P., Popoviciu, H., & Szasz, S. (2024) · Behavioral Sciences · doi:10.3390/bs14040327 · Cited by 7
“…of pain-relieving medications, including serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressants like duloxetine or milnacipran have a positive impact on both pain and emotional symptoms, particularly depression, improving functional outcomes in patients with chronic pain [127,128].”
Background
Metadata
- Authors
- Ferreira, G. E., McLachlan, A. J., Lin, C.-W. C., Zadro, J. R., Abdel-Shaheed, C., O’Keeffe, M., & Maher, C. G.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2021-01-20
- Volume
- 372
- Pages
- m4825
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W3125643582
- Cited by
- 168
- References
- 20
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.